Novartis to shutter Grimsby site amid manufacturing overhaul
Novartis has announced plans to close its manufacturing site in Grimsby, UK, by the end of 2020, among a wider job cull likely to affect more than 2,200 positions in the country and Switzerland. [...]
Tue, Sep 25, 2018
US clears Verastem’s Copiktra for blood cancers
Verastem Oncology's Copiktra has been approved in the US for the treatment relapsed or refractory chronic lymphocytic leukaemia/small lymphocytic lymphoma after at least two prior therapies. [...]
Tue, Sep 25, 2018
Farxiga cuts hospitalisation for heart failure or CV death, study shows
AstraZeneca has unveiled new data showing a statistically-significant reduction in hospitalisation for heart failure or cardiovascular (CV) death in a broad population of patients with type II diabetes taking Farxiga. [...]
Tue, Sep 25, 2018
EC clears AZ’ Imfinzi for locally-advanced, unresectable NSCLC
AstraZeneca's Imfinzi has been approved in Europe for the treatment of locally-advanced, unresectable non-small cell lung cancer (NSCLC). [...]
Tue, Sep 25, 2018

 

The Learning  Partnership